According to recent findings, the Cancer Immunotherapy Market size was valued at around USD 134.4 billion in 2024 and is projected to reach USD 214.7 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.12% during the forecast period, i.e., 2025-30.

At MarkNtel Advisors, we continuously monitor and analyze industry trends to provide reliable insights that support informed decision-making and the key factors contributing to the market's promising outlook.

Cancer Immunotherapy Overview:

The market is projected to experience significant growth due to several factors. One of the primary drivers is the increasing adoption of targeted therapy over traditional therapy, which has led to the emergence of biosimilars and increased demand for monoclonal antibodies (mAbs). The high prevalence of cancer also contributes to the rising inclination for such therapy, as immunotherapy drugs alter or boost the body's natural immune response to fight cancer. In conjugation, different immunotherapies, including CAR T-cell therapy, cancer vaccines, and immunomodulators, can be combined with other cancer treatments to achieve the best outcomes.

Explore the Insights – Download a Sample Report for Free:

Cancer Immunotherapy Outlook and Future Trends :

A Paradigm Shift from Conventional Chemotherapies to Immunotherapies Owing to Higher Efficacy of Newer Therapies - Increased research and development efforts in cancer immunotherapy have resulted in the development of advanced versions with better therapeutic efficacies. In fact, immuno-oncology has exhibited encouraging results, including improved survival and reduced toxicity. Besides, immunotherapies under research are anticipated to provide more treatment options and superior results than current medications. This has resulted in a paradigm shift from conventional chemotherapies to immunotherapies, consequently pushing the market forward. Furthermore, launching emerging medication classes targeting multiple myeloma receptors, such as monoclonal antibodies and histone deacetylase (HDAC) inhibitors, is anticipated to boost the ancer immunotherapy market growth worldwide.

 Cancer Immunotherapy Segmentation Analysis:

By Product Type

  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies and Cancer Vaccines
  • Checkpoint Inhibitors
  • Others

By Cancer Type

  • Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Head and Neck Cancer
  • Melanoma
  • Colorectal Cancer

According to reports, The lung cancer segment is the leading cancer type in the global cancer immunotherapy market by revenue and market share.

By Mechanism of Actions

  • Active Immunotherapy
  • Passive Immunotherapy

By End Users

  • Hospitals
  • Cancer Research Centers
  • Clinics

By Region

  • North America
  • Latin America
  • Europe
  • Middle East and Africa
  • Asia-Pacific.

According to reports, North America led the overall market in terms of revenue owing to the presence of numerous key players and the various strategic initiatives they have undertaken.

For deeper insights into the market, explore the summary of the research report – https://www.marknteladvisors.com/research-library/global-cancer-immunotherapy-market.html

Some of the Market players in the Cancer Immunotherapy are:

  • Amgen Inc.,
  • Astrazeneca,
  • Bayer AG,
  • Bristol-Myers Squibb,
  • ELI Lilly and Company,
  • Janssen Global Services LLC
  • Johnson and Johnson),
  • Merck,
  • Novartis,
  • Pfizer, F.
  • F. Hoffmann-La Roche AG.

Cancer Immunotherapy Recent Development:

  • In 2024: AstraZeneca decided to pay USD 18 million to Immunai (biotechnology firm) to use New York-based firm’s AI model of the immune system for cancer drug trials.

Report Delivery Format – Market research reports from MarkNtel Advisors are delivered in PDF, Excel, and PowerPoint formats. Once the payment is successfully processed, the report will be sent to your registered email within 24 hours.

Key Highlights of the Report – Unlock Valuable Market Insights

  • Market Size, Share & Future Projections – Understand the current market dimensions and forecasted growth trajectory.
  • In-Depth Pricing Analysis – Get clarity on pricing trends and cost structures across segments.
  • Company Strategies & Developments – Discover recent mergers, acquisitions, partnerships, and innovations.
  • Key Stakeholders & Value Chain Insights – Identify the main players and their roles within the industry ecosystem.
  • Import & Export Dynamics – Analyze trade flows, regional export trends, and supply chain movements.
  • Competitive Benchmarking – Gain a clear view of the leading companies and their market positioning.
  • Emerging Growth Opportunities – Spot untapped areas and niche markets for potential investment.
  • Market Trends & Growth Drivers – Stay ahead with insights into evolving consumer behavior and industry indicators.

Research Methodology Summary

A systematic approach is used to ensure accurate market insights, combining both bottom-up and top-down methods. Data triangulation validates findings from multiple angles.

Key Steps:

  • Define objectives and research design
  • Collect data through surveys and interviews
  • Analyze and validate data using reliable tools
  • Forecast trends and deliver actionable insights

Request full methodology or customized analysis - https://www.marknteladvisors.com/query/request-customization/global-cancer-immunotherapy-market.html

Read Blog:

About Us – MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: [email protected]

Visit our Website: https://www.marknteladvisors.com